新闻公告

NIBC and Blackstone agree on an amended recommended all-cash public offer for all NIBC shares
2020 年 7 月 13 日
NIBC and the Offeror have reached conditional agreement on an amended recommended all-cash public offer for all issued and outstanding shares in the capital of NIBC.
Blackstone Announces $4.6 Billion Final Close of Life Sciences Fund
2020 年 7 月 09 日
Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences V (“BXLS V”), the inaugural Blackstone fund in Life Sciences. BXLS V was oversubscribed and closed at its hard cap of $4.6 billion of total capital commitments — the largest life sciences private fund raised to date.
Blackstone Announces Second Quarter 2020 Investor Call
2020 年 7 月 01 日
Blackstone (NYSE:BX) announced today that it will host its second quarter investor conference call via public webcast on July 23, 2020 at 9:00 a.m. ET.
Hudson Pacific Properties and Blackstone Announce New Joint Venture to Expand Studio Platform
2020 年 6 月 29 日
Hudson Pacific Properties, Inc. (“Hudson Pacific”) (NYSE: HPP) and Blackstone (NYSE: BX) today announced that funds affiliated with Blackstone Property Partners will acquire a 49% interest in Hudson Pacific’s three Hollywood studios and five on-lot or adjacent Class A office properties, totaling 2.2 million square feet, at a gross portfolio valuation of $1.65 billion.
Ruth Porat, Alphabet and Google CFO, Joins Blackstone’s Board of Directors
2020 年 6 月 25 日
Ruth Porat, Alphabet and Google CFO, Joins Blackstone’s Board of Directors
Blackstone Announces Appointment of Dr. Ulrich Spiesshofer as Senior Advisor
2020 年 6 月 23 日
London, June 23 2020 - Blackstone (NYSE:BX) today announced the appointment of Dr. Ulrich Spiesshofer, former President and Chief Executive Officer of ABB Ltd, as Senior Advisor.
Medtronic Announces a $337 Million Product Investment from Blackstone Life Sciences to Expand Development of Future Diabetes Technologies
2020 年 6 月 12 日
Medtronic plc (NYSE:MDT) and Blackstone (NYSE:BX) today announced that Medtronic intends to significantly increase research and development (R&D) funding in its Diabetes Group through an agreement to receive $337 million of funding from funds managed by Blackstone Life Sciences (“BXLS”) including co-investors, aimed at advancing new, innovative products especially designed to reduce the burden of diabetes management.
Reata Pharmaceuticals, Inc. and Blackstone Life Sciences Announce $350 Million Strategic Investment
2020 年 6 月 11 日
Blackstone (NYSE: BX) and Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata”), a clinical-stage biopharmaceutical company, today announced that funds managed by Blackstone Life Sciences (“BXLS”) will lead a $350 million royalty and equity investment in Reata to fund the development and potential commercialization of bardoxolone methyl (“bardoxolone”), an investigational once-daily oral therapy being studied for chronic kidney disease (“CKD”) in Alport syndrome, autosomal dominant polycystic kidney disease (“ADPKD”), and other associated potential future indications.
Blackstone Commits Nearly $600,000 to Support COVID-19 Relief Efforts in Singapore
2020 年 6 月 05 日
Blackstone Singapore announced today a donation of nearly $600,000 to Community Chest, the fundraising and engagement arm of the National Council of Social Service. The contribution will provide assistance for vulnerable members of the community impacted by the COVID-19 outbreak and includes funding from Blackstone Singapore, its employees and the Blackstone Charitable Foundation.
Blackstone Announces Appointment of Dr. Mark McClellan, Former Head of the FDA and CMS, as Senior Advisor
2011 年 3 月 12 日
Blackstone (NYSE:BX) today announced the appointment of Dr. Mark McClellan (MD, PhD), a physician and economist who served as both the commissioner of the U.S. Food and Drug Administration (FDA) and administrator of the Centers for Medicare & Medicaid Services (CMS), as a Senior Advisor.
Blackstone to Present at the Morgan Stanley Virtual US Financials Conference
2011 年 3 月 12 日
Blackstone (NYSE:BX) announced today that Jon Gray, President & Chief Operating Officer, is scheduled to present at the Morgan Stanley Virtual US Financials Conference on Wednesday, June 10, 2020 at 12:00 pm ET.
Blackstone to Present at Bernstein’s 36th Annual Strategic Decisions Conference
2011 年 3 月 12 日
Blackstone (NYSE: BX) announced today that Stephen Schwarzman, Chairman, CEO and Co-Founder, is scheduled to present virtually at Bernstein’s 36th Annual Strategic Decisions Conference on Wednesday, May 27, 2020 at 1:30PM ET.
Blackstone Hires Vini Letteri as a Senior Managing Director for Growth Equity Investing
2011 年 3 月 12 日
Blackstone (NYSE: BX) announced that Vini Letteri will join Blackstone Growth (“BXG”), the firm’s recently launched global growth equity investing platform. He will be a Senior Managing Director and brings two decades of experience as a seasoned growth equity investor and operations professional.
Blackstone Reports First Quarter 2020 Results
2020 年 4 月 23 日
Blackstone will host its first quarter investor conference call via public webcast on April 23, 2020 at 9:00 a.m. ET.
Blackstone Announces First Quarter 2020 Investor Call
2020 年 4 月 13 日
Blackstone (NYSE:BX) announced today that it will host its first quarter investor conference call via public webcast on April 23, 2020 at 9:00 a.m. EST.
Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the Advancement of RNAi Therapeutics
2020 年 4 月 13 日
Blackstone and Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced the companies have entered into a broad strategic collaboration under which Blackstone will provide up to $2 billion to support Alnylam’s advancement of innovative RNA interference (RNAi) medicines that have the potential to transform the lives of patients suffering from a range of debilitating diseases.
Blackstone Completes Acquisition of HealthEdge Software, a Leading Healthcare Technology Solutions Provider
2020 年 4 月 09 日
New York – April 9, 2020, Blackstone (NYSE:BX) announced today that funds managed by Blackstone ("Blackstone") have completed their previously announced acquisition of a majority stake in HealthEdge Software (“HealthEdge”), a leading healthcare technology company that delivers next generation Core Administrative Processing Systems (CAPS) solutions to customers across the healthcare ecosystem.